Trailing-twelve-month (TTM) revenue is $506.21 Million with a year-over-year growth of +20.26%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q4 FY2025Period ended 2025-09-30 | $114,338,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-21 |
| Q1 FY2026Period ended 2025-12-31 | $122,462,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-04 |
| Q2 FY2026Period ended 2026-03-31 | $130,743,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-06 |
| Q3 FY2026Period ended 2026-06-30 | $138,670,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-05 |
| TTM revenue | $506,213,000 |
Current P/S: $2,803,535,518 market capitalization ÷ $506,213,000 TTM revenue = 5.54x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T15:40:28.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q3 FY2026 (2026-06-30): $138.67M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T15:41:35.815Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-09-30 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-09-30 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-09-30 · USD | FY20212021-09-30 · USD | FY20222022-09-30 · USD | FY20232023-09-30 · USD | FY20242024-09-30 · USD | FY20252025-09-30 · USD |
|---|---|---|---|---|---|---|
| Product | $248M | $266M | $290M | $331M | $305M | $297M |
| Service | $31M | $43M | $98M | $114M |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-09-30 · USD | FY20212021-09-30 · USD | FY20222022-09-30 · USD | FY20232023-09-30 · USD | FY20242024-09-30 · USD | FY20252025-09-30 · USD |
|---|---|---|---|---|---|---|
| EMEA | $40M | $46M | $54M | $70M | $65M | $63M |
| North America | $213M | $228M | $302M | $324M |
$506.21M
$506.21 Million
+20.26%
vs. $420.93M a year ago (TTM)
+10.83%
5 Year compound annual growth rate
1 Year
+20.26%
3 Year
+4.91%
5 Year
+10.83%
10 Year
+9.25%
15 Year
+6.40%
20 Year
+6.64%
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $430.22M | +$6.17M | +1.46% |
| 2024 | $424.05M | ($20.80M) | (4.68%) |
| 2023 | $444.85M | +$56.62M | +14.59% |
| 2022 | $388.23M | +$79.59M | +25.79% |
| 2021 | $308.63M | +$29.36M | +10.51% |
| 2020 |
TTM Growth
+20.26%
3-Year CAGR
+4.91%
5-Year CAGR
+10.83%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-10-06T15:41:35.815Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| $120M |
| $134M |
| $342M |
| $279.27M |
| +$25.07M |
| +9.86% |
| 2019 | $254.20M | +$27.31M | +12.04% |
| 2018 | $226.89M | +$45.26M | +24.92% |
| 2017 | $181.63M | ($21.37M) | (10.53%) |
| 2016 | $203.00M | ($842,000) | (0.41%) |
